Aisling Capital IV, LP [Rocket]

Date	Name	Symbol	Type	Security	Shares	Price	Value	Ownership	Reported
06/17/2022	Elevation Oncology, Inc.	ELEV	Grant	Stock Option (Right to Buy)	15.6k	$1.31	$20.5k	See footnote	06/17/2022
06/24/2021	Elevation Oncology, Inc.	ELEV	Grant	Director Stock Option	31.2k	$16.00	$499.8k	See Footnote	06/24/2021
12/02/2019	Zosano Pharma Corp	ZSAN	Grant	Common Stock, par value of $0.0001	689.7k	$1.45	$1000k		12/02/2019
07/15/2019	Viracta Therapeutics, Inc.	VIRX	Purchase	Common Stock	2.5M	$0.60	$1.5M	See footnote	07/15/2019
04/11/2019	Zosano Pharma Corp	ZSAN	Grant	Common Stock, par value of $0.0001	428.6k	$3.50	$1.5M		04/11/2019